首页> 外文期刊>Materials science & engineering >Ex vivo determination of chitosan/curdlan/hydroxyapatite biomaterial osseointegration with the use of human trabecular bone explant: New method for biocompatibility testing of bone implants reducing animal tests
【24h】

Ex vivo determination of chitosan/curdlan/hydroxyapatite biomaterial osseointegration with the use of human trabecular bone explant: New method for biocompatibility testing of bone implants reducing animal tests

机译:壳聚糖/姜黄素/羟基磷灰石生物材料骨整合与使用人的小梁骨外植体的新方法:骨植入物的生物相容性测试降低动物试验的新方法

获取原文
获取原文并翻译 | 示例
           

摘要

Permanent orthopedic/dental implants should reveal good osseointegration, which is defined as an ability of the biomaterial to form a direct connection with the surrounding host bone tissue after its implantation into the living organism. Currently, biomaterial osseointegration is confirmed exclusively with the use of in vivo animal tests. This study presents for the first time ex vivo determination of osseointegration process using human trabecular bone explant that was drilled and filled with the chitosan/curdlan/hydroxyapatite biomaterial, followed by its long-term culture under in vitro conditions. Within this study, it was clearly proved that tested biomaterial allows for the formation of the connection with bone explant since osteoblasts, having ability to produce bone extracellular matrix (type I collagen, fibronectin), were detected at a bone-implant interface by confocal laser scanning microscopy (CLSM) and scanning electron microscopy (SEM). Importantly, in this research it was demonstrated by Live/Dead staining and CLSM imaging that human bone explants may stay alive for a long period of time (at least approx. 50 days) during their culture under in vitro conditions. Therefore, ex vivo bone explant, which is a heterogeneous tissue containing many different cell types, may serve as an excellent model to test biomaterial osseointegration during comparative and preliminary studies, reducing animal tests which is compatible with the principles of '3Rs', aiming to Replace, Reduce and Refine the use of animals wherever possible.
机译:永久性骨科/牙科植入物应显示出良好的骨整合,这被定义为生物材料在其植入到生物体后与周围宿主骨组织直接连接的能力。目前,使用体内动物试验仅限于使用生物材料骨整合。本研究介绍了使用钻孔和填充壳聚糖/姜黄/羟基磷灰石生物材料的人的小梁骨外植体进行骨整合过程的首次测定,然后在体外条件下进行长期培养。在本研究中,清楚地证明,经过测试的生物材料允许在通过共聚焦激光器在骨植入界面中检测出骨细胞的骨质细胞(I型胶原蛋白,纤维连接蛋白)的能力以来形成与骨脱钙的连接。扫描显微镜(CLSM)和扫描电子显微镜(SEM)。重要的是,在本研究中,它是通过实时/死亡染色和CLSM成像证明,即人骨外,人骨外的植物可以在其在体外条件下培养期间长时间(至少约50天)活着。因此,作为含有许多不同细胞类型的非均相组织的离体骨脱钙可以作为在比较和初步研究期间测试生物材料渗透的优异模型,减少与“3R”原则相容的动物测试,旨在替换,减少和优化任何可能的动物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号